Shanghai Yihua Biopharmaceutical Co., Ltd.

To evaluate the efficacy and safety of Anyu Peibo capsule in the treatment of depression with placebo as control

Using placebo as a control, the safety and efficacy of Anyupeibo Capsules in the treatment of depression were evaluated, providing a scientific basis for the formulation of Phase III clinical trial plans.

To evaluate the safety and efficacy of different doses of Anyu Peibo Capsules in the treatment of depression; to preliminarily evaluate the relationship between dose and effect, and to provide a scientific basis for determining the dosing regimen (including dosage and dosing cycle) for the Phase IIb clinical trial.